MEDIROM Healthcare Technologies (MRM) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 27, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 6-K for Q2 FY2025, filed Oct 21, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MRM SEC filings page.
MEDIROM Healthcare Technologies Inc. (MRM) reported $52.7M in revenue for fiscal year 2024, up 8.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of MEDIROM Healthcare Technologies Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
MEDIROM Healthcare Technologies Inc. has an operating margin of -0.2%, meaning the company loses less than $1 on every $100 of revenue. This results in a profitability score of 27/100. This is up from -5.7% the prior year.
MEDIROM Healthcare Technologies Inc.'s revenue grew 8.8% year-over-year to $52.7M, a solid pace of expansion. This earns a growth score of 30/100.
MEDIROM Healthcare Technologies Inc. has a moderate D/E ratio of 0.82. This balance of debt and equity financing earns a leverage score of 35/100.
MEDIROM Healthcare Technologies Inc.'s current ratio of 0.65 is below the typical benchmark, resulting in a score of 7/100. This tight liquidity could limit financial flexibility if cash inflows slow.
MEDIROM Healthcare Technologies Inc.'s operations used $8.5M of cash, and capex of $454K added to the outflow, for a free cash flow shortfall of $8.9M. This results in a cash flow score of 10/100.
MEDIROM Healthcare Technologies Inc. generates a 15.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 26/100. This is down from 54.7% the prior year.
MEDIROM Healthcare Technologies Inc. scores 0.88, below the 1.81 distress threshold. The score is pulled down most by current liabilities exceeding current assets by $9.4M against total assets of $51.4M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
MEDIROM Healthcare Technologies Inc. passes 6 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, MEDIROM Healthcare Technologies Inc. used $8.95 of operating cash (-$8.5M OCF vs $945K net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
MEDIROM Healthcare Technologies Inc. reported an operating loss of $115K against $316K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q2 2025.
Cash & Balance Sheet
MEDIROM Healthcare Technologies Inc. held $227K in cash against $5.0M in long-term debt as of Q2 2025.
Not reported for Q2 2025.
Not reported for Q2 2025.
Margins & Returns
None of these metrics is reported for Q2 2025.
Capital Allocation
None of these metrics is reported for Q2 2025.
MRM Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
MRM Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'256-K | Q4'246-K | Q4'2310-K | Q4'2210-K | Q4'2110-K | Q4'2010-K | Q4'1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $55.5M | $51.4M+5.8% | $48.6M-5.1% | $51.2M+2.5% | $50.0M-9.8% | $55.4M+26.5% | $43.8M |
| Current Assets | $8.4M | $17.2M+37.8% | $12.5M-30.4% | $17.9M+49.4% | $12.0M-40.7% | $20.2M+59.4% | $12.7M |
| Cash & Equivalents | $227K | $2.1M+177.4% | $755K-83.6% | $4.6M+42.7% | $3.2M-76.9% | $14.0M+195.2% | $4.7M |
| Short-Term Investments | $43K | $39K-79.2% | $188K-6.5% | $201K-12.7% | $230K-26.9% | $315K-11.1% | $354K |
| Inventory | $1.2M | $964K-3.0% | $993K+14.7% | $866K+433.1% | $162K+110.6% | $77K+52.0% | $51K |
| Accounts Receivable | $1.3M | $8.6M+95.2% | $4.4M+8.8% | $4.1M+49.6% | $2.7M+88.4% | $1.4M-53.6% | $3.1M |
| Long-Term Investments | $606K | $555K-4.0% | $579K+43.9% | $402K-12.6% | $460K+9401.0% | $5K-96.3% | $129K |
| Goodwill | $2.6M | $2.5M-28.1% | $3.4M-16.0% | $4.1M-21.5% | $5.2M+256.9% | $1.5M+102.8% | $720K |
| Total Liabilities | $52.0M | $43.9M-6.8% | $47.1M-8.8% | $51.6M-0.2% | $51.8M+2.3% | $50.6M+32.3% | $38.3M |
| Current Liabilities | $34.6M | $26.6M+5.2% | $25.3M-8.6% | $27.6M-0.4% | $27.8M+8.0% | $25.7M+23.5% | $20.8M |
| Non-Current Liabilities | $17.4M | $17.3M-20.7% | $21.8M-9.2% | $24.0M0.0% | $24.0M-3.6% | $24.9M+42.8% | $17.4M |
| Long-Term Debt | $5.0M | $4.9M-34.9% | $7.5M-14.5% | $8.7M+34.6% | $6.5M+0.1% | $6.5M+367.6% | $1.4M |
| Total Equity | $1.7M | $5.9M+296.3% | $1.5Mn/m | -$450Kn/m | -$1.8M-138.0% | $4.8M-13.8% | $5.5M |
| Retained Earnings | -$3.2M | $1.5M+155.5% | $570Kn/m | -$19.3Mn/m | -$23.4Mn/m | -$16.5Mn/m | -$6.5M |
MRM Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
MRM Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Note: The current ratio is below 1.0 (0.65), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| MEDIROM Healthcare Technologies Inc. MRM | FY2024 | $52.7M | $945K | 1.8% | $2.9M | 23/100 |
| E-Home Household Service Holdings Limited EJH | FY2025 | $49.4M | -$3.1M | -6.4% | $4.4M | 79/100 |
| Click Holdings Limited CLIK | FY2026 | $17.3M | $1.9M | 10.8% | $6.6M | 57/100 |
| Interactive Strength Inc. TRNR | FY2025 | $11.5M | -$24.0M | N/A | $2.7M | 50/100 |
Where MEDIROM Healthcare Technologies Inc. Ranks
Frequently Asked Questions
What is MEDIROM Healthcare Technologies Inc.'s annual revenue?
MEDIROM Healthcare Technologies Inc. (MRM) reported $52.7M in total revenue for fiscal year 2024. This represents a 8.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is MEDIROM Healthcare Technologies Inc.'s revenue growing?
MEDIROM Healthcare Technologies Inc. (MRM) revenue grew by 8.8% year-over-year, from $48.5M to $52.7M in fiscal year 2024.
Is MEDIROM Healthcare Technologies Inc. profitable?
Yes, MEDIROM Healthcare Technologies Inc. (MRM) reported a net income of $945K in fiscal year 2024, with a net profit margin of 1.8%.
What is MEDIROM Healthcare Technologies Inc.'s EBITDA?
MEDIROM Healthcare Technologies Inc. (MRM) had EBITDA of $1.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does MEDIROM Healthcare Technologies Inc. have?
As of fiscal year 2024, MEDIROM Healthcare Technologies Inc. (MRM) had $2.1M in cash and equivalents against $4.9M in long-term debt.
What is MEDIROM Healthcare Technologies Inc.'s gross margin?
MEDIROM Healthcare Technologies Inc. (MRM) had a gross margin of 27.1% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is MEDIROM Healthcare Technologies Inc.'s operating margin?
MEDIROM Healthcare Technologies Inc. (MRM) had an operating margin of -0.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is MEDIROM Healthcare Technologies Inc.'s net profit margin?
MEDIROM Healthcare Technologies Inc. (MRM) had a net profit margin of 1.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is MEDIROM Healthcare Technologies Inc.'s return on equity (ROE)?
MEDIROM Healthcare Technologies Inc. (MRM) has a return on equity of 15.9% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is MEDIROM Healthcare Technologies Inc.'s free cash flow?
MEDIROM Healthcare Technologies Inc. (MRM) recorded an outflow of $8.9M in free cash flow during fiscal year 2024. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is MEDIROM Healthcare Technologies Inc.'s operating cash flow?
MEDIROM Healthcare Technologies Inc. (MRM) recorded an outflow of $8.5M in operating cash flow during fiscal year 2024, representing cash used by core business activities.
What are MEDIROM Healthcare Technologies Inc.'s total assets?
MEDIROM Healthcare Technologies Inc. (MRM) had $51.4M in total assets as of fiscal year 2024, including both current and long-term assets.
What are MEDIROM Healthcare Technologies Inc.'s capital expenditures?
MEDIROM Healthcare Technologies Inc. (MRM) invested $454K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is MEDIROM Healthcare Technologies Inc.'s current ratio?
MEDIROM Healthcare Technologies Inc. (MRM) had a current ratio of 0.65 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is MEDIROM Healthcare Technologies Inc.'s debt-to-equity ratio?
MEDIROM Healthcare Technologies Inc. (MRM) had a debt-to-equity ratio of 0.82 as of fiscal year 2024. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is MEDIROM Healthcare Technologies Inc.'s liabilities-to-equity ratio?
MEDIROM Healthcare Technologies Inc. (MRM) had a liabilities-to-equity ratio of 7.40 as of fiscal year 2024, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is MEDIROM Healthcare Technologies Inc.'s return on assets (ROA)?
MEDIROM Healthcare Technologies Inc. (MRM) had a return on assets of 1.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is MEDIROM Healthcare Technologies Inc.'s P/E ratio?
MEDIROM Healthcare Technologies Inc. (MRM) trades at 3.1x earnings, its market capitalization divided by $945K net income, FY2024. The market capitalization is $2.9M as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is MEDIROM Healthcare Technologies Inc.'s price-to-sales ratio?
MEDIROM Healthcare Technologies Inc. (MRM) trades at 0.1x sales, its market capitalization divided by $52.7M revenue, FY2024. The market capitalization is $2.9M as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does MEDIROM Healthcare Technologies Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2024, MEDIROM Healthcare Technologies Inc. (MRM) held $2.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $8.5M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is MEDIROM Healthcare Technologies Inc.'s Altman Z-Score?
MEDIROM Healthcare Technologies Inc. (MRM) has an Altman Z-Score of 0.88, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is MEDIROM Healthcare Technologies Inc.'s Piotroski F-Score?
MEDIROM Healthcare Technologies Inc. (MRM) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are MEDIROM Healthcare Technologies Inc.'s earnings high quality?
For every $1 of reported earnings, MEDIROM Healthcare Technologies Inc. (MRM) used $8.95 of operating cash (-$8.5M OCF vs $945K net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can MEDIROM Healthcare Technologies Inc. cover its interest payments?
MEDIROM Healthcare Technologies Inc. (MRM) reported an operating loss of $115K against $316K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is MEDIROM Healthcare Technologies Inc.?
MEDIROM Healthcare Technologies Inc. (MRM) scores 23 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.